GEMFIBROZIL
- Product NDC
- 43602-452
- 11-digit product format
- 436020452
- Labeler code
- 43602
- Product ID
- 43602-452_7eda8527-3245-4dbf-b057-af88b97b31ad
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gemfibrozil
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Ascent Pharmaceuticals, Inc.
- Application
- ANDA214603
- Marketing category
- ANDA
- Marketing start
- 2021-01-13
- Marketing end
- 0000-00-00
- Substance
- GEMFIBROZIL
- Active strength
- 600 mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43602-452 | GEMFIBROZIL TABLET [ASCENT PHARMACEUTICALS, INC.] | 3 | Legacy NDC | 20210116_1c23a180-fe87-4659-80a4-ade059c8f848.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43602-452-10 | 43602045210 | 1000 TABLET in 1 BOTTLE (43602-452-10) | 1000 tablet | 2021-01-13 | 0000-00-00 | No | No | Current |
| 43602-452-30 | 43602045230 | 30 TABLET in 1 BOTTLE (43602-452-30) | 30 tablet | 2021-01-13 | 0000-00-00 | No | No | Current |